Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1963 1
1965 2
1966 7
1967 12
1968 27
1969 26
1970 21
1971 35
1972 30
1973 25
1974 40
1975 30
1976 30
1977 44
1978 38
1979 49
1980 29
1981 42
1982 51
1983 58
1984 72
1985 103
1986 110
1987 160
1988 195
1989 239
1990 313
1991 394
1992 423
1993 504
1994 631
1995 714
1996 745
1997 762
1998 846
1999 954
2000 1061
2001 1234
2002 1165
2003 1342
2004 1393
2005 1578
2006 1705
2007 1650
2008 1849
2009 2012
2010 2408
2011 2769
2012 3004
2013 3472
2014 3829
2015 4057
2016 3919
2017 3894
2018 3911
2019 2047
2020 38
Text availability
Article attribute
Article type
Publication date

Search Results

50,934 results
Results by year
Filters applied: . Clear all
Page 1
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.
Moffitt RA, et al. Nat Genet 2015. PMID 26343385 Free PMC article.
Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with a 5-year survival rate of 4%. A key hallmark of PDAC is extensive stromal involvement, which makes capturing precise tumor-specific molecular information difficult. ...
Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with a 5-year survival rate of 4%. A key hallmark of PDAC is extensi …
Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression
Bernard V, et al. Clin Cancer Res 2019. PMID 30385653 Free PMC article.
PURPOSE: Early detection of pancreatic ductal adenocarcinoma (PDAC) remains elusive. Precursor lesions of PDAC, specifically intraductal papillary mucinous neoplasms (IPMNs), represent a bona fide pathway to invasive neoplasia, although the molecular correlates of progression remain to be fully elucidated. ...
PURPOSE: Early detection of pancreatic ductal adenocarcinoma (PDAC) remains elusive. Precursor lesions of PDAC, specifically intraduc …
Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors.
Romero-Calvo I, et al. Mol Cancer Res 2019. PMID 30171177 Free PMC article.
Patient-derived pancreatic ductal adenocarcinoma (PDAC) organoid systems show great promise for understanding the biological underpinnings of disease and advancing therapeutic precision medicine. ...
Patient-derived pancreatic ductal adenocarcinoma (PDAC) organoid systems show great promise for understanding the biological underpin …
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
Reis H, et al. Int J Cancer 2018. PMID 29672836 Free article.
We therefore subjected 70 urachal adenocarcinomas to targeted next-generation sequencing, conducted in situ and immunohistochemical analyses (including PD-L1 and DNA mismatch repair proteins [MMR]) and evaluated the microsatellite instability (MSI) status. ...
We therefore subjected 70 urachal adenocarcinomas to targeted next-generation sequencing, conducted in situ and immunohistochemical a …
Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis.
Boland JM, et al. Hum Pathol 2018. PMID 28823574
Invasive mucinous adenocarcinoma is a variant of lung adenocarcinoma, which may be mixed with nonmucinous adenocarcinoma. KRAS mutations are common, but other clinical and genetic features are not clearly established. ...Pulmonary invasive mucinous adenocarcinomas and mixed nonmucinous/mucinous adenocarcinomas are clinically and genetically similar, except for a higher rate of ALK rearrangement in mixed tumors. ...
Invasive mucinous adenocarcinoma is a variant of lung adenocarcinoma, which may be mixed with nonmucinous adenocarcinoma
50,934 results
Jump to page
Feedback